Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study
Oncology Research · Paul J. Chen, Jung-Ju Lin, Wei-Lin Hsu et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study?
- Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study was written by Paul J. Chen, Jung-Ju Lin, Wei-Lin Hsu, Der-Cherng Chen.
- When was Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study first published?
- Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study was first published in 2026.
Sources
Last updated · facts checked 2 November 2026
Cite this page
"Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-or-2026-086291. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.086291.